UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Manual Therapy as an Alternative Treatment Option for Idiopathic Pulmonary Fibrosis: A Case Report

Curēus (Palo Alto, CA), 2024-02

2024

Volltextzugriff (PDF)

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid

NPJ breast cancer, 2021-09, Vol.7 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Turning Barriers Into Benefits to Facilitate Public Health and Business Partnership/Comments

American journal of public health (1971), 2020-04, Vol.110 (4), p.443-446

2020

Volltextzugriff (PDF)

Misunderstood food date labels and reported food discards: A survey of U.S. consumer attitudes and behaviors

Waste management (Elmsford), 2019-03, Vol.86, p.123-132

2019

Volltextzugriff (PDF)

Impact of prior exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Breast cancer research and treatment, 2020-11, Vol.184 (1), p.87

2020

Volltextzugriff (PDF)

Impact of prior

Breast cancer research and treatment, 2020-11, Vol.184 (1), p.87

2020

Volltextzugriff (PDF)

Co-ordination of care at commencement of chemotherapy: How well do we communicate with PCPs?

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17552-e17552

2015

Volltextzugriff (PDF)

Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide

Journal of sexual medicine, 2019-08, Vol.16 (8), p.1226-1235

2019

Volltextzugriff (PDF)

Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13054-e13054

2023

Volltextzugriff (PDF)

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Breast cancer research and treatment, 2023-02, Vol.198 (1), p.67-74

2023

Volltextzugriff (PDF)

Triple-negative breast cancer: role of antiangiogenic agents

The cancer journal (Sudbury, Mass.), 2010-01, Vol.16 (1), p.33-38

2010

Volltextzugriff (PDF)

Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-35-PS6-35

2021

Volltextzugriff (PDF)

Abstract P5-04-10: Consensus guidelines for breast cancer staging during pregnancy. A Delphi Study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-04-10

2023

Volltextzugriff (PDF)

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Breast cancer research and treatment, 2020-11, Vol.184 (1), p.87-95

2020

Volltextzugriff (PDF)

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1038-1038

2020

Volltextzugriff (PDF)

Uptake of bone‐modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry

Internal medicine journal, 2022-10, Vol.52 (10), p.1707-1716

2022

Volltextzugriff (PDF)

Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study

Clinical breast cancer, 2022-10, Vol.22 (7), p.e764-e772

2022

Volltextzugriff (PDF)

Abstract P1-18-13: Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-18-13

2020

Volltextzugriff (PDF)

Abstract P5-17-05: It's as simple as ABC: Can we improve the provision of coordinated medical and supportive care to patients with advanced breast cancer?

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-17-05

2015

Volltextzugriff (PDF)

A real-world registry to evaluate HER2-directed therapy in Australian patients with metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12515-e12515

2017

Volltextzugriff (PDF)

Long term follow up (LTFU) of adjuvant zoledronic acid (ZOL) in high risk early stage breast cancer (ESBC) defined by bone marrow (BM) disseminated tumor cells (DTC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12001-e12001

2017

Volltextzugriff (PDF)

Systemic treatment of early breast cancer-a biological perspective

Journal of surgical oncology, 2011-05, Vol.103 (6), p.619-626

2011

Volltextzugriff (PDF)

Bremelanotide for Female Sexual Dysfunctions: Responder Analyses From a Phase 2B Dose-Ranging Study

Obstetrics and gynecology (New York. 1953), 2014-05, Vol.123 (Supplement 1), p.26

2014

Volltextzugriff (PDF)

Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer

Clinical breast cancer, 2010-09, Vol.10, p.S20-S29

2010

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2001-05, Vol.285 (19), p.2468

2001

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(142)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(172)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Manual Therapy as an Alternative Treatment Option for Idiopathic Pulmonary Fibrosis: A Case Report

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid

Turning Barriers Into Benefits to Facilitate Public Health and Business Partnership/Comments

Misunderstood food date labels and reported food discards: A survey of U.S. consumer attitudes and behaviors

Impact of prior exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Impact of prior

Co-ordination of care at commencement of chemotherapy: How well do we communicate with PCPs?

Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide

Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Triple-negative breast cancer: role of antiangiogenic agents

Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer

Abstract P5-04-10: Consensus guidelines for breast cancer staging during pregnancy. A Delphi Study

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

Uptake of bone‐modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry

Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study

Abstract P1-18-13: Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer

Abstract P5-17-05: It's as simple as ABC: Can we improve the provision of coordinated medical and supportive care to patients with advanced breast cancer?

A real-world registry to evaluate HER2-directed therapy in Australian patients with metastatic breast cancer (MBC)

Long term follow up (LTFU) of adjuvant zoledronic acid (ZOL) in high risk early stage breast cancer (ESBC) defined by bone marrow (BM) disseminated tumor cells (DTC)

Systemic treatment of early breast cancer-a biological perspective

Bremelanotide for Female Sexual Dysfunctions: Responder Analyses From a Phase 2B Dose-Ranging Study

Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial

Suchergebnisse filtern